Human T-lymphotropic virus type I (HTLV-I) was isolated from T-cell lymphoma and adult T-cell leukaemia' 2 and is now considered to be the causative agent of adult T-cell leukaemia/lymphoma. Recently HTLV-I was found to be associated with chronic myelopathy of unknown aetiology, that is, tropical spastic paraparesis (TSP) in equatorial countries, Martinique, Jamaica,3 off the pacific coast of Colombia,4 and Seychelles Island.5 Moreover, in south-western Japan, which is in a temperate zone, HTLV-I was found in patients with slowly progressive myelopathy. Osame et al suggested that the Japanese myelopathy, HTLV-I associated myelopathy (HAM), is a distinct clinical entity because it has not been found in a tropical area." It is believed that HAM is essentially the same as HTLV-I associated TSP, because their clinical features resemble each other.7
I
The prevalence of HTLV-I carriers in the healthy population is about 10% in south-western Japan, and HTLV-I has been found to be transmitted by breast feeding, sexual contact, and blood transfusion. Retinal vasculitis in human T-lymphotropic virus type I associated myelopathy A 49-year-old woman was admitted to the neurology department in October 1987 because of gait disturbance which had been slowly progressing for the previous five years. She also had sphincter impairment. Her serum and CSF were positive for antibodies to HTLV-I. Her husband and mother were also seropositive for HTLV-I. She was started on an oral corticosteroid preparation for myelopathy in _ . S August 1986, and the gait disturbance has been improving.
She was referred to us in September 1987 for investigation of blurred vision in the right eye that had persisted for 10 months. Her visual acuity was 20/25 OD and 20/20 OS. A large number of cells were present in the anterior vitreous in the right eye, and minimal vitreous haze was noted in the left eye. There were also some cells in the anterior chamber of the right eye. Sheathing round the veins and whitish floaters close to the retina were noted in the periphery of the inferior fundus in the right eye. Fluorescein angiogram disclosed phlebitis and hyperfluorescent areas in the same lesions (Fig. 2) . During the past year the sheathing round the vein has slowly progressed towards the posterior fundus from the periphery. CASE 3 A 50-year-old woman developed pneumonia in March 1987 followed one month later by blurred vision in both eyes. She began to stumble easily and became unable to keep herself in a standing position in August. Gait disturbance had gradually progressed to the point where she was no longer able to walk and stand in October. Sphincter impairment also developed in November. The serum and CSF were positive for antibodies to HTLV-I. She had no history of blood transfusion, and her family history contributed nothing.
When she was first examined in November 1987 her visual acuity was 20/20 in each eye. Many cells were floating in the anterior vitreous of both eyes, though the anterior chamber and lens were clear. Snowball-like opacities were noted in the lower part (Fig. 3) . There was sheathing of the vein in the periphery of the inferotemporal fundus in the right eye, but a fluorescein angiogram did not show any inflammatory changes. Interferon was given for the myelopathy, and the gait disturbance was slightly improved. It is of interest that retinal vasculitis of the left eye disappeared.
CLINICAL FEATURES OF THE THREE PATIENTS
The three patients had no lesions in the mucosa or skin (that is, ulceration of the buccal mucosa or external genitalia or erythema nodosum). They had no history of tuberculosis, and chest x-rays were normal. The laboratory data showed normal blood counts, blood chemistry, and urine analysis. The levels of angiotensin-converting enzyme in the sera were within the normal range, and serum tests for syphilis, rheumatoid arthritis, and lupus erythematosus were also negative. The serum titres of IgM and IgG antibodies against toxoplasma, herpes zoster, herpes simplex, and cytomegalovirus were low in cases 2 and 3, while IgG antibody against CMV was moderately raised in case 1. Serum antibody to human immunodeficiency virus was negative in all patients. Anti-HTLV-I antibody titres in both sera and CSF, tested by the particle aggulutination method, were strongly positive.
Discussion
We examined 12 female patients with slowly progressive myelopathy in whom the disease had its onset in adult life. Anti-HTLV-I antibodies were demonstrated in the sera and CSF of all of them. Further investigation failed to show the cause of the myelopathy, leading to the diagnosis of HTLV-I associated myelopathy (HAM). Among the clinical findings in cases of HAM and HTLV-I associated TSP not only neurological signs but also alveolitis,9 Sjogren's syndrome, and keratoconjunctivitis3 have been reported. We found retinal vasculitis in three patients with HAM. Two additional patients also presented ocular symptoms with vitreous opacity, though the funduscopic examination, including fluorescein angiography, showed no retinal vasculitis. Although retinal vasculitis extended to the posterior fundus with macular oedema and optic atrophy in case 1, the periphery of the fundus should be considered to be first involved by the vasculitis. The retinal vasculitis of these patients is characterised by phlebitis and sheathing of the veins at the periphery of the fundus.
As a cause of retinal vasculitis the coexistence of sarcoidosis, Behcet's disease, syphilis, collagen disease, and tuberculosis were ruled out. In case 1, IgG antibody against CMV was moderately raised. CMV retinitis is usually encountered in the newborn, in patients with an immunodeficient condition as a consequence of treatment for malignancy, or in patients with acquired immune deficiency syndrome (AIDS)."' However, immunodeficiency is not usually found in HAM patients, and our three patients had no clinical signs to suggest immunosuppression. CMV retinitis has characteristic appearances, including retinal haemorrhage, cotton-wool spots, and necrosis,'0 which were not observed in case 1.
The raised titre of IgG and the normal level of IgM antibodies against CMV may merely be a sign of past inapparent infection with this virus. Although noninfectious retinal vasculitis may be observed in AIDS," tests for serum antibody to human immunodeficiency virus were negative in our three patients. The above data suggest that retinal vasculitis is a part of the findings associated with HAM.
The mechanisms for the neurovirulent nature of HTLV-I remain speculative. A slow viral infection may directly infiltrate the nervous system, or an immune reaction provoked by viral infection may attack the nervous system.7 Necropsy findings in one HAM patient showed vasculitis in the spinal cord, pons, cerebrum, and cerebellum.'2 It is of interest that vasculitis could be observed by funduscope in the retina, which is a part of nervous system. Recent reports have suggested that a retrovirus similar to HTLV-I or III might play a part in the development of multiple sclerosis (MS).'3 However, the neuropathological features of HAM'2 are different from those of MS, and the waxing and waning clinical course in MS is against the slowly progressive nature of HAM. Uveitis has been found in 27% of MS patients.'4 They have sheathing of the veins and phlebitis in the periphery of the fundus, which are characterstic findings seen in HAM patients. However, optic neuritis, which is frequently found in MS, was not seen in any of our HAM patients. Optic atrophy, seen in case 1, was thought to be due to the progression of vasculitis to the posterior aspect of the retina rather than optic neuritis.
There have been few reports of ocular changes associated with HTLV-I. Ophthalmologists working in areas where the infection is endemic need to be aware of eye lesions in patients with HAM and possibly other HTLV-I related diseases.
